Ocugen   Report issue

For profit Phase 2 Phase 3
Founded: Malvern PA United States (2013)

Organization Overview

First Clinical Trial
2017
NCT03418727
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ocugen | Ocugen, Inc.